[Exogenous surfactant therapy in pediatrics]

Norberto A Freddi1, José Oliva Proença Filho, Humberto H Fiori

  • 1Hospital Santa Catarina, São Paulo, SP, Brazil. nafreddi@uol.com.br

Jornal De Pediatria
|December 4, 2003
PubMed

Insights

Exogenous surfactant therapy shows success in neonatal Respiratory Distress Syndrome (RDS), but optimal timing and use in other pediatric acute respiratory failure conditions require further investigation and improved surfactant formulations.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine
  • Biochemistry

Context:

  • Acute respiratory failure in children presents significant clinical challenges.
  • Exogenous surfactant replacement therapy is established for neonatal Respiratory Distress Syndrome (RDS).
  • Limited and conflicting data exist regarding surfactant use in other pediatric lung diseases.

Purpose:

  • To review current knowledge on exogenous surfactant use for pediatric acute respiratory failure.
  • To identify knowledge gaps and areas for future research in pediatric surfactant therapy.

Summary:

  • While successful in neonatal RDS, optimal timing of exogenous surfactant administration remains debated.
  • Surfactant efficacy in other severe pediatric lung diseases requiring ventilatory support is controversial.
  • Research is exploring surfactant inactivation mechanisms and developing novel, inhibition-resistant formulations.

Impact:

  • Highlights the need for further research into optimizing surfactant therapy for various pediatric respiratory conditions.
  • Suggests potential for improved treatment strategies through enhanced surfactant properties and targeted administration.
  • Emphasizes the importance of investigating surfactant resistance to airway inhibitors for broader clinical application.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...